By Professor Lisa Maher

Journal articles

Bajis S; Dore GJ; Hajarizadeh B; Cunningham EB; Maher L; Grebely J, 2017, 'Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review', International Journal of Drug Policy, 47, pp. 34 - 46, http://dx.doi.org/10.1016/j.drugpo.2017.07.002

Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J; Haber P; Rawlinson W; Treloar C; Maher L, 2017, 'Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study', Journal of Viral Hepatitis, 24, pp. 733 - 741, http://dx.doi.org/10.1111/jvh.12701

Dertadian GC; Dixon TC; Iversen J; Maher L, 2017, 'Self-limiting non-medical pharmaceutical opioid use among young people in Sydney, Australia: An exploratory study', Drug and Alcohol Review, 36, pp. 643 - 650, http://dx.doi.org/10.1111/dar.12474

Graham S; Maher L; Wand H; Doyle M; Iversen J, 2017, 'Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996–2015', International Journal of Drug Policy, 47, pp. 69 - 76, http://dx.doi.org/10.1016/j.drugpo.2017.06.007

Dertadian GK; Dixon T; Iversen J; Maher L, 2017, 'Pharmaceutical Opioid Use Among Oral and Intravenous Users in Australia: A Comparative Study.', International Journal of Drug Policy

Bui HTM; Le GM; Mai AQ; Zablotska-Manos I; Maher L, 2017, 'Barriers to access and uptake of antiretroviral therapy among HIV-positive men who have sex with men in Hanoi, Vietnam: from HIV testing to treatment', Culture Health and Sexuality, 19, pp. 859 - 872, http://dx.doi.org/10.1080/13691058.2016.1269203

Hope VD; Iversen J; Cullen KJ; Parry JV; Maher L; Nucbe F, 2017, 'Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms', International Journal of Drug Policy, 46, pp. 28 - 33, http://dx.doi.org/10.1016/j.drugpo.2017.05.005

Hammoud MA; Jin F; Lea T; Maher L; Grierson J; Prestage G, 2017, 'Off-Label Use of Phosphodiesterase Type 5 Inhibitor Erectile Dysfunction Medication to Enhance Sex Among Gay and Bisexual Men in Australia: Results From the FLUX Study', Journal of Sexual Medicine, 14, pp. 774 - 784, http://dx.doi.org/10.1016/j.jsxm.2017.04.670

Bartlett SR; Wertheim JO; Bull RA; Matthews GV; Lamoury FMJ; Scheffler K; Hellard M; Maher L; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2017, 'A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies', Journal of Viral Hepatitis, 24, pp. 404 - 411, http://dx.doi.org/10.1111/jvh.12652

Hengel B; Wand H; Ward J; Rumbold A; Garton L; Taylor-Thomson D; Silver B; McGregor S; Dyda A; Mein J; Knox J; Maher L; Kaldor J; Guy R; Donovan B; Han A, 2017, 'Patient, staffing and health centre factors associated with annual testing for sexually transmissible infections in remote primary health centres.', Sexual Health, 14, pp. 274 - 281, http://dx.doi.org/10.1071/SH16123

Bell S; Aggleton P; Ward J; Maher L, 2017, 'Sexual agency, risk and vulnerability: a scoping review of young Indigenous Australians’ sexual health', Journal of Youth Studies, 20, pp. 1208 - 1224, http://dx.doi.org/10.1080/13676261.2017.1317088

Iversen J; Dertadian GK; Geddes L; Maher L, 2017, 'High Risk Injecting Behaviour Among People Who Inject Pharmaceutical Opioids in Australia.', International Journal of Drug Policy

Morris MD; Shiboski S; Bruneau J; Hahn JA; Hellard M; Prins M; Cox AL; Dore G; Grebely J; Kim AY; Lauer GM; Lloyd A; Rice T; Shoukry N; Maher L; Page K, 2017, 'Geographic differences in temporal incidence trends of hepatitis C virus infection among people who inject drugs: The InC3 collaboration', Clinical Infectious Diseases, 64, pp. 860 - 869, http://dx.doi.org/10.1093/cid/ciw869

Iversen J; Dertadian G; Geddes L; Maher L, 2017, 'High risk injecting behaviour among people who inject pharmaceutical opioids in Australia', International Journal of Drug Policy, 42, pp. 1 - 6, http://dx.doi.org/10.1016/j.drugpo.2016.12.004

Rodrigo C; Walker MR; Leung P; Eltahla AA; Grebely J; Dore GJ; Applegate T; Page K; Dwivedi S; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Luciani F; Lloyd AR; Bull RA, 2017, 'Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection', Infection Genetics and Evolution, 49, pp. 88 - 96, http://dx.doi.org/10.1016/j.meegid.2017.01.006

Damon W; Small W; Anderson S; Maher L; Wood E; Kerr T; McNeil R, 2017, '‘Crisis’ and ‘everyday’ initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation', Drug and Alcohol Review, 36, pp. 253 - 260, http://dx.doi.org/10.1111/dar.12411

Hammoud MA; Jin F; Degenhardt L; Lea T; Maher L; Grierson J; Mackie B; Pastorelli M; Batrouney C; Bath N; Bradley J; Prestage GP, 2017, 'Following Lives Undergoing Change (Flux) study: Implementation and baseline prevalence of drug use in an online cohort study of gay and bisexual men in Australia', International Journal of Drug Policy, 41, pp. 41 - 50, http://dx.doi.org/10.1016/j.drugpo.2016.11.012

Dertadian G; Iversen J; Dixon TC; Sotiropoulos K; Maher L, 2017, 'Pharmaceutical opioid use among oral and intravenous users in Australia: A qualitative comparative study', International Journal of Drug Policy, 41, pp. 51 - 58, http://dx.doi.org/10.1016/j.drugpo.2016.12.007

McNeil R; Kerr T; Coleman B; Maher L; Milloy MJ; Small W, 2017, 'Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative', AIDS and Behavior, 21, pp. 402 - 409, http://dx.doi.org/10.1007/s10461-016-1470-2

Maher L; White B; Day C; Black K, 2017, 'Pregnancy incidence and contraceptive use among young women who inject drugs in Sydney, Australia', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E127 - E127, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.352

Eltahla AA; Leung P; Pirozyan MR; Rodrigo C; Grebely J; Applegate T; Maher L; Luciani F; Lloyd AR; Bull RA, 2017, 'Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment', Scientific Reports, 7, pp. 41719, http://dx.doi.org/10.1038/srep41719

Dertadian GK; Dixon T; Iversen J; Maher L, 2017, 'Self-limiting Non-Medical Pharmaceutical Opioid Use among Young People in Sydney, Australia: An Exploratory Study.', Drug and Alcohol Review

Polis S; Zablotska-Manos I; Zekry A; Maher L, 2017, 'Adherence to Hepatitis B antiviral therapy: A qualitative study', Gastroenterology Nursing, 40, pp. 239 - 246, http://dx.doi.org/10.1097/SGA.0000000000000161

Eltahla AA; Rodrigo C; Betz-Stablein B; Grebely J; Applegate T; Luciani F; Schinkel J; Dore GJ; Page K; Bruneau J; Morris MD; Cox AL; Kim AY; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Lloyd AR; Bull RA, 2017, 'Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents', Journal of Viral Hepatitis, 24, pp. 37 - 42, http://dx.doi.org/10.1111/jvh.12615

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; Dore GJ; George J; Maher L, 2017, 'Factors associated with HBV virological breakthrough', Antiviral Therapy, 22, pp. 53 - 60, http://dx.doi.org/10.3851/IMP3087

Rodrigo C; Eltahla AA; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Shoukry NH; Lauer GM; Maher L; Schinkel J; Prins M; Hellard M; Lloyd AR, 2017, 'Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study', Journal of Viral Hepatitis, 24, pp. 43 - 52, http://dx.doi.org/10.1111/jvh.12616

Platt L; Sweeney S; Ward Z; Guinness L; Hickman M; Hope V; Hutchinson S; Maher L; Iversen J; Craine N; Taylor A; Munro A; Parry J; Smith J; Vickerman P, 2017, 'Assessing the impact and cost-effectiveness of needle/syringe provision and opiate substitution therapy on hepatitis C transmission among people who inject drugs in the United Kingdom: analysis of pooled datasets and economic modelling', Public Health Research, 5, pp. 1 - 118, http://dx.doi.org/10.3310/phr05050

Iversen J; Grebely J; Catlett B; Cunningham P; Dore GD; Maher L, 2017, 'O9 Progress towards elimination: rapid uptake of HCV treatment among people who inject drugs following broad access to DAA therapies', Journal of Virus Eradication, 3, pp. 4 - 4, http://dx.doi.org/10.1016/s2055-6640(20)30892-x

Bajis S; Lamoury F; Applegate TL; Maher L; Treloar C; Mowat Y; Schulz M; Hajarizadeh B; Marshall A; Cunningham E; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Dore GJ; Grebely J, 2017, 'P4 Acceptability of point of care finger-stick and venepuncture hepatitis C virus testing among people who inject drugs and homeless people', Journal of Virus Eradication, 3, pp. 13 - 14, http://dx.doi.org/10.1016/s2055-6640(20)30745-7

Maher L; Dixon D, 2016, 'Cheaper drugs as crime control? Rethinking the drugs/crime nexus', Dialectical Anthropology, 40, pp. 343 - 348, http://dx.doi.org/10.1007/s10624-016-9419-4

Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576

Tsui JI; Mirzazadeh A; Hahn JA; Maher L; Bruneau J; Grebely J; Hellard M; Kim AY; Shoukry NH; Cox AL; Prins M; Dore GJ; Lauer G; Lloyd AR; Page K, 2016, 'The effects of alcohol on spontaneous clearance of acute hepatitis C virus infection in females versus males', Drug and Alcohol Dependence, 169, pp. 156 - 162, http://dx.doi.org/10.1016/j.drugalcdep.2016.10.024

Rodrigo C; Eltahla AA; Bull RA; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Estes C; Razavi H; Lloyd AR; Luciani F, 2016, 'Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia', Journal of Infectious Diseases, 214, pp. 1383 - 1389, http://dx.doi.org/10.1093/infdis/jiw389

Iversen J; Dertadian G; Geddes L; Maher L, 2016, 'Harms Associated with Injection of Pharmaceutical Opioids in Australia', Drug and Alcohol Review, 35, pp. 43 - 44

Dolan K; Wirtz AL; Moazen B; Ndeffo-mbah M; Galvani A; Kinner SA; Courtney R; McKee M; Amon JJ; Maher L; Hellard M; Beyrer C; Altice FL, 2016, 'Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees', Lancet, 388, pp. 1089 - 1102, http://dx.doi.org/10.1016/S0140-6736(16)30466-4

Treloar C; McCredie L; Lloyd AR; Maher L, 2016, 'The prison economy of needles and syringes: What opportunities exist for blood borne virus risk reduction when prices are so high?', Plos One, 11, pp. e0162399, http://dx.doi.org/10.1371/journal.pone.0162399

Small W; Milloy MJ; McNeil R; Maher L; Kerr T, 2016, 'Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: An ethno-epidemiological study', AIDS Research and Therapy, 13, pp. 26, http://dx.doi.org/10.1186/s12981-016-0108-9

Walker MR; Li H; Teutsch S; Betz-Stablein B; Luciani F; Lloyd AR; Bull RA; Dolan K; Maher L, 2016, 'Incident hepatitis c virus genotype distribution and multiple infection in australian prisons', Journal of Clinical Microbiology, 54, pp. 1855 - 1861, http://dx.doi.org/10.1128/JCM.00287-16

Eltahla AA; Rizzetto S; Pirozyan MR; Betz-Stablein BD; Venturi V; Kedzierska K; Lloyd AR; Bull RA; Luciani F; Maher L, 2016, 'Linking the T cell receptor to the single cell transcriptome in antigen-specific human T cells', Immunology and Cell Biology, 94, pp. 604 - 611, http://dx.doi.org/10.1038/icb.2016.16

Carrico AW; Nil E; Sophal C; Stein E; Sokunny M; Yuthea N; Evans JL; Ngak S; Maher L; Page K, 2016, 'Behavioral interventions for Cambodian female entertainment and sex workers who use amphetamine-type stimulants', Journal of Behavioral Medicine, 39, pp. 502 - 510, http://dx.doi.org/10.1007/s10865-016-9713-2

Fiches GN; Eyre NS; Aloia AL; Van Der Hoek K; Betz-Stablein B; Luciani F; Chopra A; Beard MR; Maher L, 2016, 'HCV RNA traffic and association with NS5A in living cells', Virology, 493, pp. 60 - 74, http://dx.doi.org/10.1016/j.virol.2016.02.016

Mina MM; Cameron B; Luciani F; Vollmer-Conna U; Lloyd AR; Dolan K; Maher L, 2016, 'Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users', Journal of Viral Hepatitis, 23, pp. 464 - 472, http://dx.doi.org/10.1111/jvh.12511

Draughon Moret JE; Carrico AW; Evans JL; Stein ES; Couture MC; Maher L; Page K, 2016, 'The impact of violence on sex risk and drug use behaviors among women engaged in sex work in Phnom Penh, Cambodia', Drug and Alcohol Dependence, 161, pp. 171 - 177, http://dx.doi.org/10.1016/j.drugalcdep.2016.01.028

Bull RA; Eltahla AA; Rodrigo C; Koekkoek SM; Walker M; Pirozyan MR; Betz-Stablein B; Toepfer A; Laird M; Oh S; Heiner C; Maher L; Schinkel J; Lloyd AR; Luciani F; Rasoli Pirozyan M, 2016, 'A method for near full-length amplification and sequencing for six hepatitis C virus genotypes', BMC Genomics, 17, pp. 247, http://dx.doi.org/10.1186/s12864-016-2575-8

Ivan M; Rodgers C; Maher L; Van Beek I, 2016, 'Reducing injecting-related injury and diseases in people who inject drugs: Results from a clinician-led brief intervention', Australian Family Physician, 45, pp. 129 - 133

Day CA; Shanahan M; Wand H; Topp L; Haber PS; Rodgers C; Deacon R; Walsh N; Kaldor J; van Beek I; Maher L; Lloyd A; Dore GJ; Walsh N, 2016, 'Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial', Journal of Clinical Virology, 74, pp. 66 - 72, http://dx.doi.org/10.1016/j.jcv.2015.11.031

Garton L; Dyda A; Guy R; Silver B; McGregor S; Hengel B; Rumbold A; Taylor-Thomson D; Knox J; Maher L; Kaldor J; Ward J, 2016, 'High chlamydia and gonorrhoea repeat positivity in remote Aboriginal communities 2009-2011: Longitudinal analysis of testing for re-infection at 3 months suggests the need for more frequent screening', Sexual Health, 13, pp. 568 - 574, http://dx.doi.org/10.1071/SH16025

Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection Genetics and Evolution, 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028

Page K; Mirzazadeh A; Rice TM; Grebely J; Kim AY; Cox AL; Morris MD; Hellard M; Bruneau J; Shoukry NH; Dore GJ; Maher L; Lloyd AR; Lauer G; Prins M; McGovern BH, 2016, 'Interferon lambda 4 genotype is associated with jaundice and elevated aminotransferase levels during acute hepatitis C virus infection: Findings from the InC3 collaborative', Open Forum Infectious Diseases, 3, pp. ofw024, http://dx.doi.org/10.1093/ofid/ofw024

Page K; Stein ES; Carrico AW; Evans JL; Sokunny M; Nil E; Ngak S; Sophal C; McCulloch C; Maher L, 2016, 'Protocol of a cluster randomised stepped-wedge trial of behavioural interventions targeting amphetamine-type stimulant use and sexual risk among female entertainment and sex workers in Cambodia', BMJ Open, 6, pp. e010854, http://dx.doi.org/10.1136/bmjopen-2015-010854

Back to profile page